# K052322: Bard Collamend Implant, Models 1175101, 1175102, 1175103, 1175104, 1175105

- Pathway: 510(k) (Traditional)
- Applicant: C.R. Bard, Inc.
- Decided: Apr 10, 2006 after 228 days
- Product code: FTM (Mesh, Surgical)
- Device class: 2
- Regulation: 21 CFR 878.3300
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
11 later devices descend from it; 1 cites it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Permacol® Implant: named in the summary without a submission number
- (no number) Mersilene® Polyester Fiber Mesh: named in the summary without a submission number
- (no number) FortaGen® Porcine Collagen Surgical Implant: named in the summary without a submission number

## Most influential descendants
- K063712: Avaulta Support System/Avaulta Plus Biosynthetic Support System (2007), 10 descendants of its own
- K090288: Orthadapt PR (2009), 7 descendants of its own
- K112786: Proseries Bioimplants-Proankle/Procuff (2011), 5 descendants of its own
- K220091: Poly-Tape/Infinity-Lock Soft Tissue Reinforcement Device (2022), 4 descendants of its own
- K251063: TekBrace Solo Soft Tissue Reinforcement Device (2025), 2 descendants of its own

## Indications for use
The Bard CollaMend Implant is indicated to reinforce soft tissue where weakness exists, e.g., for repair of hernia and chest wall defects, and for the surgical repair of damaged or ruptured soft tissue membranes.

Source page: https://510kreport.com/device/K052322
Methodology: https://510kreport.com/methodology